qrx003
·Code: QRX003
qrx003: developed by 2 companies · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Quoin Pharmaceuticals, Ltd. (QNRX) | Phase 2/Phase 3 |
| SKINVISIBLE, INC. (SKVI) | Phase 1 |
Clinical Trials (1)
A Single Center, Open Label, Expanded Access Study of QRX003 Lotion in Subjects With Netherton Syndrome
Frequently asked questions
Who is developing qrx003?
qrx003 is being developed by Quoin Pharmaceuticals, Ltd., SKINVISIBLE, INC..
How many clinical trials involve qrx003?
BioSniper tracks 1 clinical trial involving qrx003.
Get deeper analysis on qrx003
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis